90% of patients achieved a therapeutic response within 20 minutes that was approximately equivalent to their usual response to levodopa (n=20). APOKYN is used as needed to treat off-episode motor symptoms, including muscle stiffness, slow movements, and difficulty starting movements, associated with advanced PD.
 
 
  APOKYN is a registered trademark of Ipsen. This site is intended for use by United States residents only.
  ©2010 Tercica, Inc., an affiliate of The Ipsen Group. Authorized Distributor of Record. All rights reserved.

ABOUT SSL CERTIFICATES